pcos treatment glp-1 Navigating PCOS: How Medicines Are Changing the Game – Trim GLP-1 medications emerging as PCOS

Ahlqvist, PhD, and Hugo Sjqvist, Christina Dalman, MD, PhD, Hkan Karlsson, PhD, Olof Stephansson, MD, PhD, Stefan Johansson, MD, PhD, and Cecilia Magnusson, MD, PhD, all who hold academic appointments at the Karolinska Institutet

Bundle Options: Enhanced metabolic optimization Appetite and portion control support Long-term, results-driven care Bundle Options: Consistent appetite control Long-term weight management support A structured, provider-guided program Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality

GLP-1 receptors have been identified in various tissues involved in cardiovascular regulation, including areas of the central nervous system that influence autonomic function

The following evidence-based strategies align with NHS and NICE Clinical Knowledge Summaries (CKS) guidance